Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

MetiS and Eli Lilly sign AI-driven LNP delivery deal worth up to $1.1B

AI summary

MetiS Therapeutics (7666.HK) announced on October 19 a strategic collaboration with Eli Lilly to research and discover new lipid nanoparticle (LNP) delivery solutions, including tissue-specific delivery for multiple treatment modalities. MetiS will use its AiLNP platform, driven by the NanoForge system, to develop next-generation LNP technology aimed at improving targeting and in-vivo distribution, while Lilly contributes drug discovery, development and commercialization resources. Under the terms, MetiS receives an upfront payment of more than $10 million and is eligible for up to $1.1 billion in development, regulatory and commercial milestones, plus tiered single-digit percentage royalties on annual net sales of collaboration products. DoNews, 36Kr and TMTPost described the deal as a platform-level collaboration, and 36Kr and TMTPost called it China's first generative-AI LNP platform export deal and the largest AI-driven extrahepatic LNP delivery collaboration; these ranking claims were not independently verified.

In-depth insight

Commentary in 36Kr and TMTPost frames the agreement as Lilly paying for MetiS's reusable NanoForge platform capability rather than a single molecule, extending its AI drug-discovery stack into delivery.

10月19日消息,AI药物递送创新公司剂泰科技(7666.HK)今日宣布与礼来公司(Eli Lilly and Company)达成战略合作,聚焦新型LNP(脂质纳米颗粒)递送解决方案的研究与发现,以探索支持多种治疗模式的组织特异性递送解决方案。据公开可查交易口径,这是国内首个以生成式AI平台为核心驱动、围绕LNP递送展开的战略合作,也是全球交易规模最大的AI驱动肝外LNP递送平台合作。

根据合作协议,剂泰将依托NanoForge驱动下可离子化脂质发现与优化平台AiLNP(AI纳米递送系统设计平台),研发提升LNP递送靶向性和体内分布优化的新一代递送技术。礼来将投入其在药物发现、开发及商业化领域的优势资源,以加速双方合作的推进。

根据协议条款,剂泰科技将收取一笔逾千万美元的首付款,并有资格获得总额最高可达11亿美元的开发、监管及商业里程碑付款。此外,剂泰科技还可获得基于合作产品年度净销售额个位数百分比的分级特许权使用费。

#MetiS Therapeutics#Eli Lilly#NanoForge#AiLNP#AiTEM#Hengrui Pharmaceuticals

Original · 3 min readRead the original
Group chat

No comments yet. Start the conversation.